Phosphotyrosine Antibody Review and FAQs
  1. Mary Johnson Ph. D.
    mary at labome dot com
    Synatom Research, Princeton, New Jersey, United States
DOI
http://dx.doi.org/10.13070/mm.en.3.173
Date
last modified : 2013-12-04; original version : 2013-02-15
Cite as
MATER METHODS 2013;3:173
Phosphotyrosine Antibody

This is a review about phosphotyrosine antibodies (phospho-tyrosine antibodies), based on 78 published articles as of November 25, 2013, using phosphotyrosine antibodies in western blot, immunoprecipitation, immunocytochemistry, and other immunological technologies in randomly selected publications that Labome has been surveying systematically since 2006. Labome is continuously curating antibodies in formal publications. This review is aimed to facilitate the identification of the best-suited phosphotyrosine antibodies. Phosphotyrosine antibodies can be obtained from many suppliers. The article also addresses some of commonly asked questions about phosphotyrosine antibodies.

Phosphotyrosine Antibody Review and FAQs Figure 1
Figure 1. An example of phosphorylation studies before the usage of anti-phosphotyrosine antibodies. From [1].

Tyrosine phosphorylation is one of the major means of cell signaling transduction and enzymatic activity regulation. The advent of anti-phospho-tyrosine antibodies is one of the significant events in signal transduction research. Before the availability of anti-phosphotyrosine antibodies, tyrosyl phosphorylation of proteins and enzymes was investigated through hazardous and time-consuming radioactive experiments [1], Figure 1 examplifies such a typical experiment. Anti-phosphotyrosine antibodies are commonly used in western blots after the targeted proteins have been immunoprecipitated to measure the tyrosyl phosphorylation of the proteins. Anti-phosphotyrosine antibodies are also directly used on cell lysates to examine the overall change of tyrosine phosphorylation level in response to various treatments.

Review of other general antibodies: tag antibodies ( HA, c-Myc and His6); western blot loading controls ( beta actin, alpha tubulin); secondary antibodies.

Phosphotyrosine antibody clones

Three clones of phosphotyrosine antibodies are commonly used. They are 4G10, PY20, and p-TYR-100. PY20 clone, of IgG2b subtype, was first developed and described by Dr. John R. Glenney, Jr and his colleagues in 1988 [2]. The other two clones appear to be developed by commerical identities (Upstate 4G10 and New England Biolab p-TYR-100).

Anti-phosphotyrosine antibodies binding to the tyrosine phosphorylation peptides may exhibit substantial sequence selectivity. Michele Tinti et al. have demonstrated that different phosphotyrosine antibody clones recognize their target sites in a sequence-specific way and that this recognition differs from each other [3]. According to their peptide microarray data, although different antibody clones (i.e. 4G10, pY20 and p-TYR-100) showed a common enrichment of prolines at position +3 and leucine at position -1 with respect to the phosphorylated tyrosine in the peptides, differences between the sequence preferences were observed. For example, clone 4G10 displayed a sequence context preference for Pro, Thr, Val and Phe at position -3. Both 4G10 and p-TYR-100 bindings were likely to be hindered by a negative charge at position -1, while pY20 was more sensitive to a positive charge at the same position. Among these phosphotyrosine peptides, a total of 10%-20% could be uniquely recognized by one antibody. These specificity differences could be also reflected in Western blot, where band intensities of 4G10 and p-TYR-100 differ and pY20 even stained an additional group of 95–34 kDa proteins [3]. Since phosphorylation of tyrosine residues is a frequent modification pattern in eukaryotic cells, the sequence specificity of different anti-phosphotyrosine antibody clones would be of particular interest to researchers [3].

Phosphotyrosine antibody in literature

Table 1 lists the suppliers of phosphotyrosine antibodies among the publications surveyed by Labome.

SupplierNum
Upstate Biotechnology42
Santa Cruz Biotechnology13
BD Transduction Laboratories 12
Cell Signaling Technology4
UBI2
ICN Biomedicals2
Sigma1
Molecular Probes1
Amersham Biosciences1
Table 1. Major suppliers of phosphotyrosine antibodies and the numbers of citations among the 78 publications surveyed by Labome.

Among the 22 articles that indicated clone names, 17 articles listed 4G10, and 6 articles listed PY20 clone (one article listed both clones [4] ) .

Table 2 lists the major applications of phosphotyrosine antibodies among the publications.

ApplicationnumTop suppliers
western blot 62Upstate Biotechnology, BD Transduction Laboratories, Santa Cruz
immunoprecipitation16Upstate, Santa Cruz Biotechnology, Transduction Laboratories
immunocytochemistry6Upstate Biotechnology
immunohistochemistry 2
Table 2. Applications of phosphotyrosine antibodies and their numbers of citations among the 78 publications surveyed by Labome.
Phosphotyrosine antibodies from individual suppliers

Anti-phosphotyrosine antibodies from specific suppliers are enumerated here.

Upstate Biotechnology/EMD Millipore

Upstate Biotechnology is now part of EMD Millipore.

Upstate Biotechnology has been providing some of most commonly used anti-phospho-tyrosine antibodies, including the most commonly used clone 4G10. More than half of the publications cited Upstate anti-phospho-tyrosine antibodies in western blot, immunoprecipitation, and immunocytochemistry.

Upstate anti-phosphotyrosine antibody was used to perform western blot and immunohistochemistry in order to study the function of sema3E-plexin D1 [5], to perform immunoprecipitation in order to study the roles of LRP1 in the adult CNS [6], and western blot analysis (clone 4G10) in order to determine the receptor property of erythropoietin receptor during receptor signaling activation [7] and to study the effect of the facilitation of AMPA receptor synaptic delivery on cognitive enhancement [8].

Among papers published earlier in 2001, K Aoyama used 4G10 in western blot to study a novel dual specificity phosphatase, LMW-DSP2; K Sauer et al. used 4G10 in western blot to examine the interaction of HPK1 with BLNK in B cells and with SLP-76 in T cells, A E Aplin et al. used 4G10 in western blot to study the regulation of ERK nuclear translocation and Elk-1 phosphorylation by integrin-mediated adhesion; H Konishi et al. used it in western blot to study the tyrosine phosphorylation sites of PKC delta in the H2O2-treated cells; C C Chen used both clone PY-20 and clone 4G10 in western blot and immunocytochemistry to study the induction of adhesive signaling in primary human skin fibroblasts; C Gilbert used 4G10 in immunoprecipitation to evaluate the SAM68 roles in signal transduction during human neutrophil phagocytosis.

In 2002, clone 4G10 was used in western blots by Matthew N Poy to study the mitogenic action of insulin regulated by Shc and CEACAM1 interaction, by Kenneth L Byron to examine vasopressin signal transduction in A7r5 vascular smooth muscle cells, by Diane Lejeune et al. to study STAT3 serine phosphorylation, and in immunocytochemistry by Ann L Moor to localize tyrosine-phosphorylated PLC (pY-PLC) in HTC cells.

In 2003, Yosuke Minami et al. conducted western blot experiments with Upstate Biotechnology antiphosphotyrosine antibody to differentiate the antiapoptotic pathways between wild-type and mutated FLT3; K C Leung et al. used 4G10 in western blot to study the inhibiting effects of estrogen on transcriptional action of GH through the SOCS-2 mediated JAK/STAT pathway; John H Griffin used 4G10 in western blot to study a fusion kinase in EOL-1 cells and the idiopathic hypereosinophilic syndrome.

Matthew L Jones in 2004 used 4G10 to immunoprecipitate phosphorylated SHP-1 proteins; Tod A Brown used anti-phosphotyrosine monoclonal antibody in western blot to elucidate the tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia; Charng-Jui Chen et al. used 4G10 in western blot and immunocytochemistry to investigate the inhibition of IL-2 production and proliferation in human T cells by carcinoembryonic antigen-related cellular adhesion molecule 1.

In 2005, Upstate Biotechnology anti-phosphotyrosine antibodies were used in western blots to examine the Rac-MKK3/6-p38 pathway in breast epithelial cells by Ilchung Chin, the regulation of the endothelial cell response to Ang-1 through stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor by Ilaria Cascone et al., the direct interaction between human CNK1 and Raf-1 by Algirdas Ziogas et al., and T-cell receptor-induced activation of phospholipase C-gamma1 by a sequence-independent function of the P-I region of SLP-76 by Ronnie Gonen et al.. Upstate Biotech anti-phosphotyrosine antibody was used in immunoprecipitation to study the phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture by Dr. Amanchy in 2005.

Upstate Biotechnology anti-phosphotyrosine (1:3000) was used in western blot to demonstrate that lipid rafts sequester Ret away from the degradation machinery to sustain Ret signaling by Dr. Pierchala in 2006. Upstate/Millipore 4G10 antibody was used in western blot to study the role of MNAR in 17beta-estradiol (E2)-induced activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by Dr.Greger in 2007. Additional citations include [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [7] [19] [20] [21] [8] [22] [23] [24] [25] [26] [4] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [6] [44] [5].

Santa Cruz Biotechnology

Among the publications [45] [46] [47] [48] [49] [50] [51] [52] [53] [31] [30] [54], Santa Cruz antiphosphotyrosine (anti-pTyr) antibody was used in western blots to study the downregulation of the Ras-mitogen-activated protein kinase pathway by S Elowe in 2001, and to study the role of beta-arrestin in ubiquitination and IGF-1 receptor down-regulation by Leonard Girnita in 2005; its PY20 anti-phosphotyrosine antibody was used in immunoprecipitation to study the IL-2 production and proliferation in human T cells inhibited by the cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 by Charng-Jui Chen 2004; Matthew N Poy in 2002 also used anti-phosphotyrosine antibody (PY20) in immunoprecipitation to study the regulation of insulin mitogenic action by Shc and CEACAM1 interaction, and Santa Cruz Biotechnology phosphotyrosine antibody was used in western blot to investigated the mechanism and function of ubiquitination of protease-activated receptor 2 (PAR2) by Dr. Jacob in 2005. Santa Cruz Biotechnology mouse monoclonal anti-phosphotyrosine antibody was used to perform western blot to investigate the roles of Vav2 and Vav3 in skin cancer [55].

Transduction Laboratories/BD Biosciences

Publications citing BD Biosciences anti-phosphotyrosine antibodies include [56] [57] [58] [59] [60] [10] [61] [62] [63] [64] [65] [28], where Koichi Seta in 2003 used BD Biosciences horseradish peroxidase-conjugated anti-phosphotyrosine monoclonal antibody (RC20H) in western blot to study the angiotensin II-induced trans-activation of the EGF receptor and found that the transactivation was mediated by phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor; the same clone was used by C Sweeney in 2001 in western blot to examine ErbB receptor-mediated signaling pathway stimulation and gene expression; Wen Hong Shen et al.in 2004 used a different mouse anti-phosphotyrosine clone (PY20) in both western blot and immunoprecipitation to study cyclin A expression and retinoblastoma hyperphosphorylation; polyclonal anti-phosphotyrosine antibody was used in immunoprecipitation to study vasopressin-induced signal transduction in A7r5 vascular smooth muscle cells by Kenneth L Byron in 2002; and peroxidase-conjugated anti-phosphotyrosine antibody was used in western blots to exploit EphA2 as a therapeutic target of cancer by Dr. Koolpe in 2002.

Cell Signaling Technology

Cell Signaling Technology phosphotyrosine antibody was used in western blot and immunoprecipitation to study the role of p68 RNA helicase [66], in western blot to study cell adhesion molecule [67] and vIL-6 18987143] and its monoclonal mouse anti-phosphotyrosine antibody was used in immunocytochemistry to study supervillin [68].

ICN Biomedicals/MPBIO

ICN Biomedicals monoclonal anti-phosphotyrosine antibody PY20 in western blot to study the involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in beta-hydroxyisovalerylshikon-induced apoptosis [69] and the role of aldose reductase pathway during myocardial ischemic injury [70].

Sigma

In 2001, L You used Sigma monoclonal phosphotyrosine antibody in western blot to study migration and signal transduction induced by cell-derived neurotrophic factor (GDNF) in corneal epithelial cells [71].

Amersham Biosciences/GE Health Science

Amersham Biosciences monoclonal anti-phosphotyrosine horseradish peroxidase-conjugated antibody was used in western blot to study insulin receptor catalytic activity inhibition by in 2002 [72].

Commonly asked questions about phosphotyrosine antibodies.

Some of the commonly asked questions are answered here.

How to detect tyrosine phosphorylation of a specific protein?

There are several ways.

  1. use a phosphorylation-specific antibody against the specific protein.
  2. use an antibody against the specific protein to immunoprecipitate both phosphorylated or non-phosphorylated forms of the specific protein, then detect with phosphotyrosine antibodies in Western blot.
  3. use phosphotyrosine antibodies to immunoprecipitate all tyrosine-phosphorylated proteins, and then detect with an antibody against the specific protein.
  4. mass spec.

For detailed discussion of the detection of protein phosphorylation, see Labome article about Protein Modification Research Methods.

During Western blotting of phosphotyrosine antibodies, should nonfat dry milk or BSA be used as the blocking agent?

BSA should be used, since nonfat dry milk contains proteins that are phosphorylated at tyrosine residues.

How long can the lysate samples be stored before detection of tyrosine phosphorylation?

The samples should generally be used fresh, since the proteins might be degraded, and dephosphorylation may occur due to phosphatases.

Is there any anti-phosphotyrosine anybody that can be used to neutralize or block the activities of protein kinases or phosphatases?

We do not know the answer to this question. Anti-phosphotyrosine anybodies have been used for Western blot, immunoprecipitation, immunocytochemistry, and immunohistochemistry.

References
  1. Ushiro H, Cohen S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem. 1980;255:8363-5 PMID 6157683
  2. Blaivas J, Scott R, Labib K. Urodynamic evaluation as neurologic test of sacral cord function. Urology. 1979;13:682-7 PMID 452204
  3. Tinti M, Nardozza A, Ferrari E, Sacco F, Corallino S, Castagnoli L, et al. The 4G10, pY20 and p-TYR-100 antibody specificity: profiling by peptide microarrays. N Biotechnol. 2012;29:571-7 PMID 22178400 CrossRef
  4. Chen C, Chen N, Lau L. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem. 2001;276:10443-52 PMID 11120741
  5. Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz J, Rizzolio S, et al. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J Clin Invest. 2010;120:2684-98 PMID 20664171 CrossRef
  6. Liu Q, Zhang J, Zerbinatti C, Zhan Y, Kolber B, Herz J, et al. Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system. PLoS Biol. 2011;9:e1000575 PMID 21264353 CrossRef
  7. Becker V, Schilling M, Bachmann J, Baumann U, Raue A, Maiwald T, et al. Covering a broad dynamic range: information processing at the erythropoietin receptor. Science. 2010;328:1404-8 PMID 20488988 CrossRef
  8. Knafo S, Venero C, Sánchez-Puelles C, Pereda-Pérez I, Franco A, Sandi C, et al. Facilitation of AMPA receptor synaptic delivery as a molecular mechanism for cognitive enhancement. PLoS Biol. 2012;10:e1001262 PMID 22363206 CrossRef
  9. Ballif B, Arnaud L, Cooper J. Tyrosine phosphorylation of Disabled-1 is essential for Reelin-stimulated activation of Akt and Src family kinases. Brain Res Mol Brain Res. 2003;117:152-9 PMID 14559149
  10. Aidoudi S, Bujakowska K, Kieffer N, Bikfalvi A. The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis. PLoS ONE. 2008;3:e2657 PMID 18648521 CrossRef
  11. Zheng R, Friedman A, Levis M, Li L, Weir E, Small D. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expression. Blood. 2004;103:1883-90 PMID 14592841
  12. Greger J, Fursov N, Cooch N, McLarney S, Freedman L, Edwards D, et al. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase. Mol Cell Biol. 2007;27:1904-13 PMID 17194752
  13. Pierchala B, Milbrandt J, Johnson E. Glial cell line-derived neurotrophic factor-dependent recruitment of Ret into lipid rafts enhances signaling by partitioning Ret from proteasome-dependent degradation. J Neurosci. 2006;26:2777-87 PMID 16525057
  14. Cariappa A, Takematsu H, Liu H, Diaz S, Haider K, Boboila C, et al. B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med. 2009;206:125-38 PMID 19103880 CrossRef
  15. Cheung V, Nayak R, Wang I, Elwyn S, Cousins S, Morley M, et al. Polymorphic cis- and trans-regulation of human gene expression. PLoS Biol. 2010;8: PMID 20856902
  16. Feng L, Cooper J. Dual functions of Dab1 during brain development. Mol Cell Biol. 2009;29:324-32 PMID 18981215 CrossRef
  17. Jakus Z, Simon E, Frommhold D, Sperandio M, Mocsai A. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. J Exp Med. 2009;206:577-93 PMID 19273622 CrossRef
  18. Kim H, Zhang K, Zhang L, Ross F, Teitelbaum S, Faccio R. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. Proc Natl Acad Sci U S A. 2009;106:2325-30 PMID 19171907 CrossRef
  19. Matsumoto T, Hosono-Nishiyama K, Yamada H. A pectic polysaccharide isolated from the roots of Bupleurum falcatum L. stimulates the tyrosine phosphorylation of lipid rafts of murine B cells. Biol Pharm Bull. 2008;31:931-4 PMID 18451521
  20. Mazaki Y, Hashimoto S, Okawa K, Tsubouchi A, Nakamura K, Yagi R, et al. An ADP-ribosylation factor GTPase-activating protein Git2-short/KIAA0148 is involved in subcellular localization of paxillin and actin cytoskeletal organization. Mol Biol Cell. 2001;12:645-62 PMID 11251077
  21. Xu X, Harder J, Flynn D, Lanier L. AFAP120 regulates actin organization during neuronal differentiation. Differentiation. 2009;77:38-47 PMID 19281763 CrossRef
  22. Haj F, Zabolotny J, Kim Y, Kahn B, Neel B. Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice. J Biol Chem. 2005;280:15038-46 PMID 15699041
  23. Mifune M, Ohtsu H, Suzuki H, Frank G, Inagami T, Utsunomiya H, et al. Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells. Am J Physiol Cell Physiol. 2004;287:C807-13 PMID 15163624
  24. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa J, Renauld J. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002;277:33676-82 PMID 12087100
  25. Konishi H, Yamauchi E, Taniguchi H, Yamamoto T, Matsuzaki H, Takemura Y, et al. Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci U S A. 2001;98:6587-92 PMID 11381116
  26. Aplin A, Stewart S, Assoian R, Juliano R. Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol. 2001;153:273-82 PMID 11309409
  27. Gonen R, Beach D, Ainey C, Yablonski D. T cell receptor-induced activation of phospholipase C-gamma1 depends on a sequence-independent function of the P-I region of SLP-76. J Biol Chem. 2005;280:8364-70 PMID 15623534
  28. Byron K, Lucchesi P. Signal transduction of physiological concentrations of vasopressin in A7r5 vascular smooth muscle cells. A role for PYK2 and tyrosine phosphorylation of K+ channels in the stimulation of Ca2+ spiking. J Biol Chem. 2002;277:7298-307 PMID 11739373
  29. Sauer K, Liou J, Singh S, Yablonski D, Weiss A, Perlmutter R. Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes. J Biol Chem. 2001;276:45207-16 PMID 11487585
  30. Poy M, Ruch R, Fernstrom M, Okabayashi Y, Najjar S. Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem. 2002;277:1076-84 PMID 11694516
  31. Chen C, Shively J. The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association with Src homology protein-1 and down-regulates IL-2 receptor. J Immunol. 2004;172:3544-52 PMID 15004155
  32. Cascone I, Napione L, Maniero F, Serini G, Bussolino F. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol. 2005;170:993-1004 PMID 16157706
  33. Leung K, Doyle N, Ballesteros M, Sjogren K, Watts C, Low T, et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci U S A. 2003;100:1016-21 PMID 12552091
  34. Minami Y, Yamamoto K, Kiyoi H, Ueda R, Saito H, Naoe T. Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia. Blood. 2003;102:2969-75 PMID 12842996
  35. Shin I, Kim S, Song H, Kim H, Moon A. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem. 2005;280:14675-83 PMID 15677464
  36. Moore A, Roe M, Melnick R, Lidofsky S. Calcium mobilization evoked by hepatocellular swelling is linked to activation of phospholipase Cgamma. J Biol Chem. 2002;277:34030-5 PMID 12167665
  37. Griffin J, Leung J, Bruner R, Caligiuri M, Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci U S A. 2003;100:7830-5 PMID 12808148
  38. Amanchy R, Kalume D, Iwahori A, Zhong J, Pandey A. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J Proteome Res. 2005;4:1661-71 PMID 16212419
  39. Yu J, Liu X, Kim H. Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53. J Biol Chem. 2003;278:49582-8 PMID 14506245
  40. Liang S, Zhang W, Horuzsko A. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur J Immunol. 2006;36:2457-71 PMID 16897816
  41. Ueki K, Fruman D, Yballe C, Fasshauer M, Klein J, Asano T, et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem. 2003;278:48453-66 PMID 14504291
  42. Brown T, Yang T, Zaitsevskaia T, Xia Y, Dunn C, Sigle R, et al. Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia. J Biol Chem. 2004;279:14772-83 PMID 14739293
  43. Ziogas A, Moelling K, Radziwill G. CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation. J Biol Chem. 2005;280:24205-11 PMID 15845549
  44. Tessmer M, Fugere C, Stevenaert F, Naidenko O, Chong H, Leclercq G, et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol. 2007;19:391-400 PMID 17307799
  45. Miller B, Bronk J, Nishiyama T, Yamagiwa H, Srivastava A, Bolander M, et al. Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. J Endocrinol. 2007;192:505-13 PMID 17332520
  46. Huron D, Gorre M, Kraker A, Sawyers C, Rosen N, Moasser M. A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. Clin Cancer Res. 2003;9:1267-73 PMID 12684394
  47. Klessner J, Desai B, Amargo E, Getsios S, Green K. EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol Cell. 2009;20:328-37 PMID 18987342 CrossRef
  48. Girnita L, Shenoy S, Sehat B, Vasilcanu R, Girnita A, Lefkowitz R, et al. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J Biol Chem. 2005;280:24412-9 PMID 15878855
  49. Guo H, Lee I, Bryan B, Pierce M. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway. J Biol Chem. 2005;280:8332-42 PMID 15615721
  50. Proietti C, Rosemblit C, Beguelin W, Rivas M, Díaz Flaqué M, Charreau E, et al. Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth. Mol Cell Biol. 2009;29:1249-65 PMID 19103753 CrossRef
  51. Jacob C, Cottrell G, Gehringer D, Schmidlin F, Grady E, Bunnett N. c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J Biol Chem. 2005;280:16076-87 PMID 15708858
  52. Beazely M, Lim A, Li H, Trepanier C, Chen X, Sidhu B, et al. Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons. J Biol Chem. 2009;284:8054-63 PMID 19106110 CrossRef
  53. Shimada K, Nakamura M, Ishida E, Higuchi T, Yamamoto H, Tsujikawa K, et al. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Sci. 2008;99:39-45 PMID 17970783
  54. Elowe S, Holland S, Kulkarni S, Pawson T. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol Cell Biol. 2001;21:7429-41 PMID 11585923
  55. Menacho-Marquez M, García-Escudero R, Ojeda V, Abad A, Delgado P, Costa C, et al. The Rho exchange factors Vav2 and Vav3 favor skin tumor initiation and promotion by engaging extracellular signaling loops. PLoS Biol. 2013;11:e1001615 PMID 23935450 CrossRef
  56. Paliouras G, Naujokas M, Park M. Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor. Mol Cell Biol. 2009;29:3018-32 PMID 19289496 CrossRef
  57. Sweeney C, Fambrough D, Huard C, Diamonti A, Lander E, Cantley L, et al. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J Biol Chem. 2001;276:22685-98 PMID 11297548
  58. Xu G, Craig A, Greer P, Miller M, Anastasiadis P, Lilien J, et al. Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase Fer. J Cell Sci. 2004;117:3207-19 PMID 15226396
  59. Furne C, Ricard J, Cabrera J, Pays L, Bethea J, Mehlen P, et al. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. Biochim Biophys Acta. 2009;1793:231-8 PMID 18948148 CrossRef
  60. Koolpe M, Dail M, Pasquale E. An ephrin mimetic peptide that selectively targets the EphA2 receptor. J Biol Chem. 2002;277:46974-9 PMID 12351647
  61. Kirsch K, Kensinger M, Hanafusa H, August A. A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling. BMC Cell Biol. 2002;3:18 PMID 12119061
  62. Taniguchi K, Maeda R, Ando T, Okumura T, Nakazawa N, Hatori R, et al. Chirality in planar cell shape contributes to left-right asymmetric epithelial morphogenesis. Science. 2011;333:339-41 PMID 21764746 CrossRef
  63. Shen W, Yin Y, Broussard S, McCusker R, Freund G, Dantzer R, et al. Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J Biol Chem. 2004;279:7438-46 PMID 14681231
  64. Horvath E, Tackett L, McCarthy A, Raman P, Brozinick J, Elmendorf J. Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance. Mol Endocrinol. 2008;22:937-50 PMID 18165437 CrossRef
  65. Seta K, Sadoshima J. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J Biol Chem. 2003;278:9019-26 PMID 12522132
  66. Yang L, Lin C, Zhao S, Wang H, Liu Z. Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression. J Biol Chem. 2007;282:16811-9 PMID 17412694
  67. He Q, Meiri K. Isolation and characterization of detergent-resistant microdomains responsive to NCAM-mediated signaling from growth cones. Mol Cell Neurosci. 2002;19:18-31 PMID 11817895
  68. Crowley J, Smith T, Fang Z, Takizawa N, Luna E. Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency. Mol Biol Cell. 2009;20:948-62 PMID 19109420 CrossRef
  69. Hwang Y, Shaw S, Kaneko M, Redd H, Marrero M, Ramasamy R. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury. FASEB J. 2005;19:795-7 PMID 15746188
  70. Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S, et al. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem. 2004;279:42503-15 PMID 15292218
  71. You L, Ebner S, Kruse F. Glial cell-derived neurotrophic factor (GDNF)-induced migration and signal transduction in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:2496-504 PMID 11581189
  72. Bereziat V, Kasus-Jacobi A, Perdereau D, Cariou B, Girard J, Burnol A. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14. J Biol Chem. 2002;277:4845-52 PMID 11726652
ISSN : 2329-5139